Possible help in fight against muscle-wasting disease

University of Oregon-University of Rochester team finds compound that reverses type 1 myotonic dystrophy

		IMAGE: Andrew Berglund, a member of the University of Oregon's Institute of Molecular Biology, studies myotonic dystrophy. His team has found an existing FDA-approved compound for a variety of diseases might... Click here for more information.

A compound already used to treat pneumonia could become a new therapy for an inherited muscular wasting disease, according to researchers at the University of Oregon and the University of Rochester School of Medicine and Dentistry in New York.